drugset / Trial / NCT00705406
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether peramivir is safe and effective in the treatment of uncomplicated seasonal influenza.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-04
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 600 mg | Intramuscular |